ARTICLE | Clinical News
Zytiga abiraterone acetate regulatory update
July 25, 2011 7:00 AM UTC
EMA's CHMP issued a positive opinion recommending approval of an MAA for Zytiga abiraterone acetate from Johnson & Johnson's Janssen-Cilag International N.V. subsidiary in combination with prednisone ...